Dejan Micic

Dejan Micic practices at The University of Chicago Medical Center in Chicago, Illinois.

Dejan Micic's NPI, 1356660203, was assigned on May 18, 2010. Dejan Micic graduated from University of Wisconsin School of Medicine in 2010. Dejan Micic holds Illinois license 036132320.

Dejan Micic's primary practice is The University of Chicago Medical Center, at 5841 S Maryland Ave, Chicago, IL 60637 in Cook County. The practice phone is (773) 702-1530.

Dejan Micic's primary practice is The University of Chicago Medical Center in Chicago, Illinois. Dejan Micic is also affiliated with Loyola University Medical Center. The medical group on file is Loyola University Medical Center. Dmand AI also links Dejan Micic to 2 more hospitals, 4 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dejan Micic practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dejan Micic's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dejan Micic is licensed in Illinois.

CMS data shows 414 Medicare services from Dejan Micic across 11 procedure codes in 2024, for 284 Medicare patients. Medicare paid $52,714 for them.

CMS counts 284 Medicare patients who saw Dejan Micic in 2024. The largest group is 65 to 74, with 128 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 2.24, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dejan Micic's median patient age at 67, with 57% women.

In 2024, Dejan Micic wrote 586 Medicare Part D claims for 174 patients. 80% of them were for generic drugs. CMS names the drug for 420 of them, across 17 drugs with 11 or more claims each, at $627,443 in total drug cost. In 2023, CMS named 381 claims across 15 drugs.

Dejan Micic accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dejan Micic as offering telehealth. CMS counts 60 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dejan Micic, more than 66% of the clinicians it reports for that procedure.

Dmand AI links 104 papers to Dejan Micic, published from 2012 to 2025. 2020 was the busiest year, with 15. The most frequent topics are Inflammatory Bowel Diseases, Clostridioides difficile and Colitis, Ulcerative. Dejan Micic has published most often in Dig Dis Sci. Dejan Micic's most frequent co-authors are Atsushi Sakuraba, MD, Shintaro Akiyama, MD and Vijaya L. Rao.

CMS Open Payments shows 83 general payments to Dejan Micic from 17 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 50% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $72,346.

Dejan Micic graduated from University of Wisconsin School of Medicine in 2010.